Tenofovir Df + Emtricitabine + Rilpivirine Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: TDF – 300 mg + Emtricitabine – 200 mg + Rilpivirine – 25 mg

Reference Brands: Complera(US); Eviplera(EU)

Category: Anti Viral

Tenofovir DF + Emtricitabine + Rilpivirine is available in Tablet and strengths such as TDF – 300 mg + Emtricitabine – 200 mg + Rilpivirine – 25 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tenofovir DF + Emtricitabine + Rilpivirine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Tenofovir DF + Emtricitabine + Rilpivirine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Tenofovir Disoproxil Fumarate (TDF) + Emtricitabine + Rilpivirine is a once-daily, fixed-dose combination used for the treatment of HIV-1 infection in treatment-naïve adults and adolescents. Marketed under the brand names Complera (US) and Eviplera (EU), it combines three powerful antiretroviral agents: TDF (a nucleotide reverse transcriptase inhibitor), Emtricitabine (an NRTI), and Rilpivirine (a non-nucleoside reverse transcriptase inhibitor). This single-tablet regimen simplifies HIV treatment, enhances patient adherence, and effectively suppresses viral load. Approved by the FDA and EMA, it is recommended for patients without resistance to any of its components and should be taken with a meal for optimal absorption.